Pharyngitis Therapeutics Market - Regional Insights

Pharyngitis treatment is majorly based on the symptoms, depending the cause of pharyngitis for example, bacterial, fungal, and herpes simplex infections. The common symptoms of pharyngitis include sneezing, runny nose, headache, cough, fatigue, body aches, chills, and fever. Additionally, strep throat condition also occurs, which may lead to difficulty in swallowing, loss of appetite, nausea, fever, loss of taste, and swollen lymph nodes. Pain medication such as NSAIDs and acetaminophen are used to reduce the pain associated with pharyngitis. Besides, Aspirin is also used by adults, however, not recommended for children due to risk of occurrence of Reye syndrome.

Furthermore, steroids such as dexamethasone are also useful for treating pharyngitis. If the infection is caused by bacteria, then these steroids are taken with antibiotics, however, if caused by virus, antibiotics shows no positive results. Moreover, oral analgesic solutions are also prescribed with active ingredient phenol as a medication for pharyngitis. Wide range of options available for treatment of pharyngitis, in turn supports growth of the pharyngitis therapeutics market.

Get The Holistic SAMPLE Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/2001

Pharyngitis Therapeutics Market Dynamics

According to the study published in 2016, by the Centers for Disease Control and Prevention (CDC) and Pew Charitable Trusts, doctors are often prescribing the wrong antibiotics, which concluded that only 52% of the 44 million antibiotic prescribed for sinus infections, middle ear infections, and pharyngitis are the first-line drugs. Furthermore, in 2017, the World Health Organization (WHO) released a report suggesting that there is a serious lack of new antibiotics in development, underscoring that antibiotic resistance is a global health emergency set to undermine the decades of progress in modern medicine.

Therefore, manufactures are increasingly focusing on research and development for new discovery of antibiotics or any other therapeutic drugs to treat pharyngitis. For instance, Innovative Med Concepts, Inc. is in the process of developing a promising treatment for pharyngitis i.e the company’s second novel product NRP-1—a proprietary throat spray—is designed to treat viral pharyngitis, which is expected to serve the large unmet medical needs and cause of most cases of pharyngitis. NRP-1 will also provide the required relief for cancer patients undergoing head and neck radiation plagued with disabling oral mucositis/pharyngitis. This spray delivers medication, which then adheres to the posterior pharynx despite repeated swallows and saliva.

Download The PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/2001

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website:https://www.coherentwire.com

This release was published on openPR.